id	sid	tid	token	lemma	pos
cord-261186-4p1cwb2e	1	1	key	key	JJ
cord-261186-4p1cwb2e	1	2	:	:	:
cord-261186-4p1cwb2e	1	3	cord-261186	cord-261186	NNP
cord-261186-4p1cwb2e	1	4	-	-	HYPH
cord-261186-4p1cwb2e	1	5	4p1cwb2e	4p1cwb2e	CD
cord-261186-4p1cwb2e	1	6	authors	author	NNS
cord-261186-4p1cwb2e	1	7	:	:	:
cord-261186-4p1cwb2e	1	8	Guzman	Guzman	NNP
cord-261186-4p1cwb2e	1	9	-	-	HYPH
cord-261186-4p1cwb2e	1	10	Prado	Prado	NNP
cord-261186-4p1cwb2e	1	11	,	,	,
cord-261186-4p1cwb2e	2	1	Yuli	Yuli	NNP
cord-261186-4p1cwb2e	2	2	title	title	NN
cord-261186-4p1cwb2e	2	3	:	:	:
cord-261186-4p1cwb2e	2	4	Recent	recent	JJ
cord-261186-4p1cwb2e	2	5	findings	finding	NNS
cord-261186-4p1cwb2e	2	6	on	on	IN
cord-261186-4p1cwb2e	2	7	cardiovascular	cardiovascular	JJ
cord-261186-4p1cwb2e	2	8	safety	safety	NN
cord-261186-4p1cwb2e	2	9	with	with	IN
cord-261186-4p1cwb2e	2	10	the	the	DT
cord-261186-4p1cwb2e	2	11	use	use	NN
cord-261186-4p1cwb2e	2	12	of	of	IN
cord-261186-4p1cwb2e	2	13	chloroquine	chloroquine	NN
cord-261186-4p1cwb2e	2	14	and	and	CC
cord-261186-4p1cwb2e	2	15	hydroxychloroquine	hydroxychloroquine	NN
cord-261186-4p1cwb2e	2	16	for	for	IN
cord-261186-4p1cwb2e	2	17	COVID-19	COVID-19	NNP
cord-261186-4p1cwb2e	2	18	.	.	.
cord-261186-4p1cwb2e	2	19	date	date	NN
cord-261186-4p1cwb2e	2	20	:	:	:
cord-261186-4p1cwb2e	2	21	2020	2020	CD
cord-261186-4p1cwb2e	2	22	-	-	HYPH
cord-261186-4p1cwb2e	2	23	06	06	CD
cord-261186-4p1cwb2e	2	24	-	-	HYPH
cord-261186-4p1cwb2e	2	25	09	09	CD
cord-261186-4p1cwb2e	2	26	journal	journal	NN
cord-261186-4p1cwb2e	2	27	:	:	:
cord-261186-4p1cwb2e	3	1	Am	be	VBP
cord-261186-4p1cwb2e	3	2	J	J	NNP
cord-261186-4p1cwb2e	3	3	Cardiol	Cardiol	NNP
cord-261186-4p1cwb2e	4	1	DOI	DOI	NNP
cord-261186-4p1cwb2e	5	1	:	:	:
cord-261186-4p1cwb2e	5	2	10.1016	10.1016	CD
cord-261186-4p1cwb2e	5	3	/	/	SYM
cord-261186-4p1cwb2e	5	4	j.amjcard.2020.06.003	j.amjcard.2020.06.003	NN
cord-261186-4p1cwb2e	5	5	sha	sha	NNP
cord-261186-4p1cwb2e	5	6	:	:	:
cord-261186-4p1cwb2e	6	1	1b85df584f5cf05e01077673229b523c18ed1f9d	1b85df584f5cf05e01077673229b523c18ed1f9d	CD
cord-261186-4p1cwb2e	6	2	doc_id	doc_id	CD
cord-261186-4p1cwb2e	6	3	:	:	:
cord-261186-4p1cwb2e	6	4	261186	261186	CD
cord-261186-4p1cwb2e	6	5	cord_uid	cord_uid	NNS
cord-261186-4p1cwb2e	6	6	:	:	:
cord-261186-4p1cwb2e	7	1	4p1cwb2e	4p1cwb2e	CD
cord-261186-4p1cwb2e	7	2	nan	nan	NNP
cord-261186-4p1cwb2e	7	3	and	and	CC
cord-261186-4p1cwb2e	7	4	found	find	VBD
cord-261186-4p1cwb2e	7	5	no	no	DT
cord-261186-4p1cwb2e	7	6	significant	significant	JJ
cord-261186-4p1cwb2e	7	7	differences	difference	NNS
cord-261186-4p1cwb2e	7	8	in	in	IN
cord-261186-4p1cwb2e	7	9	the	the	DT
cord-261186-4p1cwb2e	7	10	likelihood	likelihood	NN
cord-261186-4p1cwb2e	7	11	of	of	IN
cord-261186-4p1cwb2e	7	12	abnormal	abnormal	JJ
cord-261186-4p1cwb2e	7	13	electrocardiogram	electrocardiogram	NN
cord-261186-4p1cwb2e	7	14	findings	finding	NNS
cord-261186-4p1cwb2e	7	15	(	(	-LRB-
cord-261186-4p1cwb2e	7	16	defined	define	VBN
cord-261186-4p1cwb2e	7	17	as	as	IN
cord-261186-4p1cwb2e	7	18	arrhythmia	arrhythmia	NN
cord-261186-4p1cwb2e	7	19	or	or	CC
cord-261186-4p1cwb2e	7	20	prolonged	prolong	VBN
cord-261186-4p1cwb2e	7	21	QT	qt	NN
cord-261186-4p1cwb2e	7	22	interval	interval	NN
cord-261186-4p1cwb2e	7	23	)	)	-RRB-
cord-261186-4p1cwb2e	7	24	between	between	IN
cord-261186-4p1cwb2e	7	25	groups	group	NNS
cord-261186-4p1cwb2e	7	26	,	,	,
cord-261186-4p1cwb2e	7	27	however	however	RB
cord-261186-4p1cwb2e	7	28	,	,	,
cord-261186-4p1cwb2e	7	29	the	the	DT
cord-261186-4p1cwb2e	7	30	researchers	researcher	NNS
cord-261186-4p1cwb2e	7	31	highlight	highlight	VBP
cord-261186-4p1cwb2e	7	32	that	that	IN
cord-261186-4p1cwb2e	7	33	cardiac	cardiac	JJ
cord-261186-4p1cwb2e	7	34	arrest	arrest	NN
cord-261186-4p1cwb2e	7	35	was	be	VBD
cord-261186-4p1cwb2e	7	36	more	more	RBR
cord-261186-4p1cwb2e	7	37	likely	likely	JJ
cord-261186-4p1cwb2e	7	38	in	in	IN
cord-261186-4p1cwb2e	7	39	the	the	DT
cord-261186-4p1cwb2e	7	40	group	group	NN
cord-261186-4p1cwb2e	7	41	treated	treat	VBN
cord-261186-4p1cwb2e	7	42	with	with	IN
cord-261186-4p1cwb2e	7	43	HCQ	HCQ	NNP
cord-261186-4p1cwb2e	7	44	plus	plus	CC
cord-261186-4p1cwb2e	7	45	AZ	AZ	NNP
cord-261186-4p1cwb2e	7	46	(	(	-LRB-
cord-261186-4p1cwb2e	7	47	adjusted	adjust	VBN
cord-261186-4p1cwb2e	7	48	OR	or	CC
cord-261186-4p1cwb2e	7	49	2.13	2.13	CD
cord-261186-4p1cwb2e	7	50	;	;	:
cord-261186-4p1cwb2e	7	51	95	95	CD
cord-261186-4p1cwb2e	7	52	%	%	NN
cord-261186-4p1cwb2e	7	53	CI	CI	NNP
cord-261186-4p1cwb2e	7	54	1.12	1.12	CD
cord-261186-4p1cwb2e	7	55	-4.05	-4.05	CD
cord-261186-4p1cwb2e	7	56	)	)	-RRB-
cord-261186-4p1cwb2e	7	57	.	.	.
cord-261186-4p1cwb2e	8	1	No	no	DT
cord-261186-4p1cwb2e	8	2	significant	significant	JJ
cord-261186-4p1cwb2e	8	3	differences	difference	NNS
cord-261186-4p1cwb2e	8	4	in	in	IN
cord-261186-4p1cwb2e	8	5	in	in	IN
cord-261186-4p1cwb2e	8	6	-	-	HYPH
cord-261186-4p1cwb2e	8	7	hospital	hospital	NN
cord-261186-4p1cwb2e	8	8	mortality	mortality	NN
cord-261186-4p1cwb2e	8	9	were	be	VBD
cord-261186-4p1cwb2e	8	10	found	find	VBN
cord-261186-4p1cwb2e	8	11	.	.	.
cord-261186-4p1cwb2e	9	1	In	in	IN
cord-261186-4p1cwb2e	9	2	order	order	NN
cord-261186-4p1cwb2e	9	3	to	to	TO
cord-261186-4p1cwb2e	9	4	elucidate	elucidate	VB
cord-261186-4p1cwb2e	9	5	if	if	IN
cord-261186-4p1cwb2e	9	6	the	the	DT
cord-261186-4p1cwb2e	9	7	finding	finding	NN
cord-261186-4p1cwb2e	9	8	of	of	IN
cord-261186-4p1cwb2e	9	9	cardiac	cardiac	JJ
cord-261186-4p1cwb2e	9	10	arrest	arrest	NN
cord-261186-4p1cwb2e	9	11	was	be	VBD
cord-261186-4p1cwb2e	9	12	mediated	mediate	VBN
cord-261186-4p1cwb2e	9	13	or	or	CC
cord-261186-4p1cwb2e	9	14	not	not	RB
cord-261186-4p1cwb2e	9	15	by	by	IN
cord-261186-4p1cwb2e	9	16	mechanical	mechanical	JJ
cord-261186-4p1cwb2e	9	17	ventilation	ventilation	NN
cord-261186-4p1cwb2e	9	18	,	,	,
cord-261186-4p1cwb2e	9	19	the	the	DT
cord-261186-4p1cwb2e	9	20	authors	author	NNS
cord-261186-4p1cwb2e	9	21	performed	perform	VBD
cord-261186-4p1cwb2e	9	22	a	a	DT
cord-261186-4p1cwb2e	9	23	stratified	stratified	JJ
cord-261186-4p1cwb2e	9	24	analysis	analysis	NN
cord-261186-4p1cwb2e	9	25	and	and	CC
cord-261186-4p1cwb2e	9	26	indicated	indicate	VBD
cord-261186-4p1cwb2e	9	27	that	that	IN
cord-261186-4p1cwb2e	9	28	in	in	IN
cord-261186-4p1cwb2e	9	29	the	the	DT
cord-261186-4p1cwb2e	9	30	group	group	NN
cord-261186-4p1cwb2e	9	31	of	of	IN
cord-261186-4p1cwb2e	9	32	patients	patient	NNS
cord-261186-4p1cwb2e	9	33	who	who	WP
cord-261186-4p1cwb2e	9	34	did	do	VBD
cord-261186-4p1cwb2e	9	35	not	not	RB
cord-261186-4p1cwb2e	9	36	receive	receive	VB
cord-261186-4p1cwb2e	9	37	mechanical	mechanical	JJ
cord-261186-4p1cwb2e	9	38	ventilation	ventilation	NN
cord-261186-4p1cwb2e	9	39	,	,	,
cord-261186-4p1cwb2e	9	40	the	the	DT
cord-261186-4p1cwb2e	9	41	risk	risk	NN
cord-261186-4p1cwb2e	9	42	for	for	IN
cord-261186-4p1cwb2e	9	43	cardiac	cardiac	JJ
cord-261186-4p1cwb2e	9	44	arrest	arrest	NN
cord-261186-4p1cwb2e	9	45	remained	remain	VBD
cord-261186-4p1cwb2e	9	46	increased	increase	VBN
cord-261186-4p1cwb2e	9	47	for	for	IN
cord-261186-4p1cwb2e	9	48	HCQ	HCQ	NNP
cord-261186-4p1cwb2e	9	49	alone	alone	RB
cord-261186-4p1cwb2e	9	50	compared	compare	VBN
cord-261186-4p1cwb2e	9	51	with	with	IN
cord-261186-4p1cwb2e	9	52	AZ	AZ	NNP
cord-261186-4p1cwb2e	9	53	alone	alone	JJ
cord-261186-4p1cwb2e	9	54	(	(	-LRB-
cord-261186-4p1cwb2e	9	55	adjusted	adjust	VBN
cord-261186-4p1cwb2e	9	56	OR	or	CC
cord-261186-4p1cwb2e	9	57	3.01	3.01	CD
cord-261186-4p1cwb2e	9	58	95	95	CD
cord-261186-4p1cwb2e	9	59	%	%	NN
cord-261186-4p1cwb2e	9	60	CI	CI	NNP
cord-261186-4p1cwb2e	9	61	1.07	1.07	CD
cord-261186-4p1cwb2e	9	62	-	-	HYPH
cord-261186-4p1cwb2e	9	63	8.51	8.51	CD
cord-261186-4p1cwb2e	9	64	)	)	-RRB-
cord-261186-4p1cwb2e	9	65	.	.	.
cord-261186-4p1cwb2e	10	1	The	the	DT
cord-261186-4p1cwb2e	10	2	analysis	analysis	NN
cord-261186-4p1cwb2e	10	3	performed	perform	VBN
cord-261186-4p1cwb2e	10	4	in	in	IN
cord-261186-4p1cwb2e	10	5	this	this	DT
cord-261186-4p1cwb2e	10	6	study	study	NN
cord-261186-4p1cwb2e	10	7	was	be	VBD
cord-261186-4p1cwb2e	10	8	adjusted	adjust	VBN
cord-261186-4p1cwb2e	10	9	for	for	IN
cord-261186-4p1cwb2e	10	10	likely	likely	JJ
cord-261186-4p1cwb2e	10	11	confounders	confounder	NNS
cord-261186-4p1cwb2e	10	12	,	,	,
cord-261186-4p1cwb2e	10	13	including	include	VBG
cord-261186-4p1cwb2e	10	14	comorbidities	comorbiditie	NNS
cord-261186-4p1cwb2e	10	15	,	,	,
cord-261186-4p1cwb2e	10	16	demographics	demographic	NNS
cord-261186-4p1cwb2e	10	17	and	and	CC
cord-261186-4p1cwb2e	10	18	disease	disease	NN
cord-261186-4p1cwb2e	10	19	severity	severity	NN
cord-261186-4p1cwb2e	10	20	.	.	.
cord-261186-4p1cwb2e	11	1	However	however	RB
cord-261186-4p1cwb2e	11	2	,	,	,
cord-261186-4p1cwb2e	11	3	due	due	IN
cord-261186-4p1cwb2e	11	4	to	to	IN
cord-261186-4p1cwb2e	11	5	the	the	DT
cord-261186-4p1cwb2e	11	6	observational	observational	JJ
cord-261186-4p1cwb2e	11	7	study	study	NN
cord-261186-4p1cwb2e	11	8	design	design	NN
cord-261186-4p1cwb2e	11	9	it	-PRON-	PRP
cord-261186-4p1cwb2e	11	10	is	be	VBZ
cord-261186-4p1cwb2e	11	11	possible	possible	JJ
cord-261186-4p1cwb2e	11	12	that	that	IN
cord-261186-4p1cwb2e	11	13	some	some	DT
cord-261186-4p1cwb2e	11	14	amount	amount	NN
cord-261186-4p1cwb2e	11	15	of	of	IN
cord-261186-4p1cwb2e	11	16	unmeasured	unmeasured	JJ
cord-261186-4p1cwb2e	11	17	confounding	confounding	JJ
cord-261186-4p1cwb2e	11	18	remains	remain	NNS
cord-261186-4p1cwb2e	11	19	.	.	.
cord-261186-4p1cwb2e	12	1	Later	later	RB
cord-261186-4p1cwb2e	12	2	on	on	RB
cord-261186-4p1cwb2e	12	3	,	,	,
cord-261186-4p1cwb2e	12	4	Mehra	Mehra	NNP
cord-261186-4p1cwb2e	12	5	et	et	NNP
cord-261186-4p1cwb2e	12	6	al	al	NNP
cord-261186-4p1cwb2e	12	7	(	(	-LRB-
cord-261186-4p1cwb2e	12	8	9	9	CD
cord-261186-4p1cwb2e	12	9	)	)	-RRB-
cord-261186-4p1cwb2e	12	10	,	,	,
cord-261186-4p1cwb2e	12	11	reported	report	VBD
cord-261186-4p1cwb2e	12	12	a	a	DT
cord-261186-4p1cwb2e	12	13	large	large	JJ
cord-261186-4p1cwb2e	12	14	international	international	JJ
cord-261186-4p1cwb2e	12	15	observational	observational	JJ
cord-261186-4p1cwb2e	12	16	registry	registry	NN
cord-261186-4p1cwb2e	12	17	including	include	VBG
cord-261186-4p1cwb2e	12	18	data	datum	NNS
cord-261186-4p1cwb2e	12	19	from	from	IN
cord-261186-4p1cwb2e	12	20	96032	96032	CD
cord-261186-4p1cwb2e	12	21	patients	patient	NNS
cord-261186-4p1cwb2e	12	22	from	from	IN
cord-261186-4p1cwb2e	12	23	671	671	CD
cord-261186-4p1cwb2e	12	24	hospitals	hospital	NNS
cord-261186-4p1cwb2e	12	25	in	in	IN
cord-261186-4p1cwb2e	12	26	six	six	CD
cord-261186-4p1cwb2e	12	27	continents	continent	NNS
cord-261186-4p1cwb2e	12	28	(	(	-LRB-
cord-261186-4p1cwb2e	12	29	mainly	mainly	RB
cord-261186-4p1cwb2e	12	30	North	North	NNP
cord-261186-4p1cwb2e	12	31	America	America	NNP
cord-261186-4p1cwb2e	12	32	and	and	CC
cord-261186-4p1cwb2e	12	33	Europe	Europe	NNP
cord-261186-4p1cwb2e	12	34	)	)	-RRB-
cord-261186-4p1cwb2e	12	35	who	who	WP
cord-261186-4p1cwb2e	12	36	received	receive	VBD
cord-261186-4p1cwb2e	12	37	CQ	CQ	NNP
cord-261186-4p1cwb2e	12	38	(	(	-LRB-
cord-261186-4p1cwb2e	12	39	n=1868	n=1868	NNP
cord-261186-4p1cwb2e	12	40	)	)	-RRB-
cord-261186-4p1cwb2e	12	41	;	;	:
cord-261186-4p1cwb2e	12	42	CQ	CQ	NNP
cord-261186-4p1cwb2e	12	43	plus	plus	CC
cord-261186-4p1cwb2e	12	44	macrolide	macrolide	NN
cord-261186-4p1cwb2e	12	45	(	(	-LRB-
cord-261186-4p1cwb2e	12	46	n=3783	n=3783	CD
cord-261186-4p1cwb2e	12	47	)	)	-RRB-
cord-261186-4p1cwb2e	12	48	;	;	:
cord-261186-4p1cwb2e	12	49	HCQ	HCQ	NNP
cord-261186-4p1cwb2e	12	50	(	(	-LRB-
cord-261186-4p1cwb2e	12	51	n=3016	n=3016	NN
cord-261186-4p1cwb2e	12	52	)	)	-RRB-
cord-261186-4p1cwb2e	12	53	;	;	:
cord-261186-4p1cwb2e	12	54	HCQ	hcq	NN
cord-261186-4p1cwb2e	12	55	plus	plus	CC
cord-261186-4p1cwb2e	12	56	macrolide	macrolide	NN
cord-261186-4p1cwb2e	12	57	(	(	-LRB-
cord-261186-4p1cwb2e	12	58	n=6221	n=6221	NFP
cord-261186-4p1cwb2e	12	59	)	)	-RRB-
cord-261186-4p1cwb2e	12	60	versus	versus	IN
cord-261186-4p1cwb2e	12	61	none	none	NN
cord-261186-4p1cwb2e	12	62	of	of	IN
cord-261186-4p1cwb2e	12	63	these	these	DT
cord-261186-4p1cwb2e	12	64	drugs	drug	NNS
cord-261186-4p1cwb2e	12	65	(	(	-LRB-
cord-261186-4p1cwb2e	12	66	n=81144	n=81144	CD
cord-261186-4p1cwb2e	12	67	)	)	-RRB-
cord-261186-4p1cwb2e	12	68	and	and	CC
cord-261186-4p1cwb2e	12	69	found	find	VBD
cord-261186-4p1cwb2e	12	70	that	that	IN
cord-261186-4p1cwb2e	12	71	the	the	DT
cord-261186-4p1cwb2e	12	72	use	use	NN
cord-261186-4p1cwb2e	12	73	of	of	IN
cord-261186-4p1cwb2e	12	74	CQ	CQ	NNP
cord-261186-4p1cwb2e	12	75	or	or	CC
cord-261186-4p1cwb2e	12	76	HCQ	HCQ	NNP
cord-261186-4p1cwb2e	12	77	with	with	IN
cord-261186-4p1cwb2e	12	78	or	or	CC
cord-261186-4p1cwb2e	12	79	without	without	IN
cord-261186-4p1cwb2e	12	80	macrolides	macrolide	NNS
cord-261186-4p1cwb2e	12	81	was	be	VBD
cord-261186-4p1cwb2e	12	82	independently	independently	RB
cord-261186-4p1cwb2e	12	83	associated	associate	VBN
cord-261186-4p1cwb2e	12	84	with	with	IN
cord-261186-4p1cwb2e	12	85	a	a	DT
cord-261186-4p1cwb2e	12	86	higher	high	JJR
cord-261186-4p1cwb2e	12	87	risk	risk	NN
cord-261186-4p1cwb2e	12	88	of	of	IN
cord-261186-4p1cwb2e	12	89	in	in	IN
cord-261186-4p1cwb2e	12	90	-	-	HYPH
cord-261186-4p1cwb2e	12	91	hospital	hospital	NN
cord-261186-4p1cwb2e	12	92	mortality	mortality	NN
cord-261186-4p1cwb2e	12	93	and	and	CC
cord-261186-4p1cwb2e	12	94	an	an	DT
cord-261186-4p1cwb2e	12	95	increased	increase	VBN
cord-261186-4p1cwb2e	12	96	frequency	frequency	NN
cord-261186-4p1cwb2e	12	97	of	of	IN
cord-261186-4p1cwb2e	12	98	de	de	JJ
cord-261186-4p1cwb2e	12	99	-	-	JJ
cord-261186-4p1cwb2e	12	100	novo	novo	JJ
cord-261186-4p1cwb2e	12	101	ventricular	ventricular	JJ
cord-261186-4p1cwb2e	12	102	arrhythmia	arrhythmia	NN
cord-261186-4p1cwb2e	12	103	(	(	-LRB-
cord-261186-4p1cwb2e	12	104	non	non	JJ
cord-261186-4p1cwb2e	12	105	-	-	JJ
cord-261186-4p1cwb2e	12	106	sustained	sustained	JJ
cord-261186-4p1cwb2e	12	107	or	or	CC
cord-261186-4p1cwb2e	12	108	sustained	sustain	VBN
cord-261186-4p1cwb2e	12	109	ventricular	ventricular	JJ
cord-261186-4p1cwb2e	12	110	tachycardia	tachycardia	JJ
cord-261186-4p1cwb2e	12	111	or	or	CC
cord-261186-4p1cwb2e	12	112	ventricular	ventricular	JJ
cord-261186-4p1cwb2e	12	113	fibrillation	fibrillation	NN
cord-261186-4p1cwb2e	12	114	)	)	-RRB-
cord-261186-4p1cwb2e	12	115	.	.	.
cord-261186-4p1cwb2e	13	1	The	the	DT
cord-261186-4p1cwb2e	13	2	authors	author	NNS
cord-261186-4p1cwb2e	13	3	state	state	VBP
cord-261186-4p1cwb2e	13	4	that	that	IN
cord-261186-4p1cwb2e	13	5	the	the	DT
cord-261186-4p1cwb2e	13	6	combination	combination	NN
cord-261186-4p1cwb2e	13	7	of	of	IN
cord-261186-4p1cwb2e	13	8	CQ	CQ	NNP
cord-261186-4p1cwb2e	13	9	or	or	CC
cord-261186-4p1cwb2e	13	10	HCQ	HCQ	NNP
cord-261186-4p1cwb2e	13	11	with	with	IN
cord-261186-4p1cwb2e	13	12	a	a	DT
cord-261186-4p1cwb2e	13	13	macrolide	macrolide	NN
cord-261186-4p1cwb2e	13	14	increased	increase	VBD
cord-261186-4p1cwb2e	13	15	the	the	DT
cord-261186-4p1cwb2e	13	16	hazard	hazard	NN
cord-261186-4p1cwb2e	13	17	of	of	IN
cord-261186-4p1cwb2e	13	18	de	de	NNP
cord-261186-4p1cwb2e	13	19	-	-	JJ
cord-261186-4p1cwb2e	13	20	novo	novo	JJ
cord-261186-4p1cwb2e	13	21	ventricular	ventricular	JJ
cord-261186-4p1cwb2e	13	22	arrhythmias	arrhythmias	RB
cord-261186-4p1cwb2e	13	23	:	:	:
cord-261186-4p1cwb2e	13	24	CQ	CQ	NNP
cord-261186-4p1cwb2e	13	25	with	with	IN
cord-261186-4p1cwb2e	13	26	a	a	DT
cord-261186-4p1cwb2e	13	27	macrolide	macrolide	NN
cord-261186-4p1cwb2e	13	28	(	(	-LRB-
cord-261186-4p1cwb2e	13	29	HR	HR	NNP
cord-261186-4p1cwb2e	13	30	4.01	4.01	CD
cord-261186-4p1cwb2e	13	31	;	;	:
cord-261186-4p1cwb2e	13	32	95	95	CD
cord-261186-4p1cwb2e	13	33	%	%	NN
cord-261186-4p1cwb2e	13	34	CI	CI	NNP
cord-261186-4p1cwb2e	13	35	3.34	3.34	CD
cord-261186-4p1cwb2e	13	36	-4.81	-4.81	CD
cord-261186-4p1cwb2e	13	37	)	)	-RRB-
cord-261186-4p1cwb2e	13	38	;	;	:
cord-261186-4p1cwb2e	13	39	CQ	CQ	NNP
cord-261186-4p1cwb2e	13	40	alone	alone	RB
cord-261186-4p1cwb2e	13	41	(	(	-LRB-
cord-261186-4p1cwb2e	13	42	HR	HR	NNP
cord-261186-4p1cwb2e	13	43	3.56	3.56	CD
cord-261186-4p1cwb2e	13	44	;	;	:
cord-261186-4p1cwb2e	13	45	95	95	CD
cord-261186-4p1cwb2e	13	46	%	%	NN
cord-261186-4p1cwb2e	13	47	CI	CI	NNP
cord-261186-4p1cwb2e	13	48	2.76	2.76	CD
cord-261186-4p1cwb2e	13	49	-4.59	-4.59	CD
cord-261186-4p1cwb2e	13	50	)	)	-RRB-
cord-261186-4p1cwb2e	13	51	;	;	:
cord-261186-4p1cwb2e	13	52	HCQ	HCQ	NNP
cord-261186-4p1cwb2e	13	53	with	with	IN
cord-261186-4p1cwb2e	13	54	a	a	DT
cord-261186-4p1cwb2e	13	55	macrolide	macrolide	NN
cord-261186-4p1cwb2e	13	56	(	(	-LRB-
cord-261186-4p1cwb2e	13	57	HR	HR	NNP
cord-261186-4p1cwb2e	13	58	5.10	5.10	CD
cord-261186-4p1cwb2e	13	59	;	;	:
cord-261186-4p1cwb2e	13	60	95	95	CD
cord-261186-4p1cwb2e	13	61	%	%	NN
cord-261186-4p1cwb2e	13	62	CI	ci	NN
cord-261186-4p1cwb2e	14	1	4.10	4.10	CD
cord-261186-4p1cwb2e	14	2	-5.98	-5.98	CD
cord-261186-4p1cwb2e	14	3	)	)	-RRB-
cord-261186-4p1cwb2e	15	1	and	and	CC
cord-261186-4p1cwb2e	15	2	HCQ	HCQ	NNP
cord-261186-4p1cwb2e	15	3	alone	alone	JJ
cord-261186-4p1cwb2e	15	4	(	(	-LRB-
cord-261186-4p1cwb2e	15	5	HR	HR	NNP
cord-261186-4p1cwb2e	15	6	2.36	2.36	CD
cord-261186-4p1cwb2e	15	7	;	;	:
cord-261186-4p1cwb2e	15	8	95	95	CD
cord-261186-4p1cwb2e	15	9	%	%	NN
cord-261186-4p1cwb2e	15	10	CI	CI	NNP
cord-261186-4p1cwb2e	15	11	1.93	1.93	CD
cord-261186-4p1cwb2e	15	12	-2.90	-2.90	CD
cord-261186-4p1cwb2e	15	13	)	)	-RRB-
cord-261186-4p1cwb2e	15	14	.	.	.
cord-261186-4p1cwb2e	16	1	Predictors	predictor	NNS
cord-261186-4p1cwb2e	16	2	of	of	IN
cord-261186-4p1cwb2e	16	3	ventricular	ventricular	JJ
cord-261186-4p1cwb2e	16	4	arrhythmia	arrhythmia	NN
cord-261186-4p1cwb2e	16	5	were	be	VBD
cord-261186-4p1cwb2e	16	6	also	also	RB
cord-261186-4p1cwb2e	16	7	investigated	investigate	VBN
cord-261186-4p1cwb2e	16	8	and	and	CC
cord-261186-4p1cwb2e	16	9	the	the	DT
cord-261186-4p1cwb2e	16	10	variables	variable	NNS
cord-261186-4p1cwb2e	16	11	found	find	VBN
cord-261186-4p1cwb2e	16	12	to	to	TO
cord-261186-4p1cwb2e	16	13	be	be	VB
cord-261186-4p1cwb2e	16	14	independently	independently	RB
cord-261186-4p1cwb2e	16	15	associated	associate	VBN
cord-261186-4p1cwb2e	16	16	with	with	IN
cord-261186-4p1cwb2e	16	17	higher	high	JJR
cord-261186-4p1cwb2e	16	18	risk	risk	NN
cord-261186-4p1cwb2e	16	19	of	of	IN
cord-261186-4p1cwb2e	16	20	de	de	NNP
cord-261186-4p1cwb2e	16	21	-	-	JJ
cord-261186-4p1cwb2e	16	22	novo	novo	JJ
cord-261186-4p1cwb2e	16	23	ventricular	ventricular	JJ
cord-261186-4p1cwb2e	16	24	arrhythmias	arrhythmia	NNS
cord-261186-4p1cwb2e	16	25	were	be	VBD
cord-261186-4p1cwb2e	16	26	CQ	CQ	NNP
cord-261186-4p1cwb2e	16	27	or	or	CC
cord-261186-4p1cwb2e	16	28	HCQ	HCQ	NNP
cord-261186-4p1cwb2e	16	29	with	with	IN
cord-261186-4p1cwb2e	16	30	or	or	CC
cord-261186-4p1cwb2e	16	31	without	without	IN
cord-261186-4p1cwb2e	16	32	macrolides	macrolide	NNS
cord-261186-4p1cwb2e	16	33	and	and	CC
cord-261186-4p1cwb2e	16	34	baseline	baseline	JJ
cord-261186-4p1cwb2e	16	35	comorbidities	comorbiditie	NNS
cord-261186-4p1cwb2e	16	36	such	such	JJ
cord-261186-4p1cwb2e	16	37	as	as	IN
cord-261186-4p1cwb2e	16	38	coronary	coronary	JJ
cord-261186-4p1cwb2e	16	39	artery	artery	NN
cord-261186-4p1cwb2e	16	40	disease	disease	NN
cord-261186-4p1cwb2e	16	41	,	,	,
cord-261186-4p1cwb2e	16	42	congestive	congestive	JJ
cord-261186-4p1cwb2e	16	43	heart	heart	NN
cord-261186-4p1cwb2e	16	44	failure	failure	NN
cord-261186-4p1cwb2e	16	45	,	,	,
cord-261186-4p1cwb2e	16	46	history	history	NN
cord-261186-4p1cwb2e	16	47	of	of	IN
cord-261186-4p1cwb2e	16	48	cardiac	cardiac	JJ
cord-261186-4p1cwb2e	16	49	arrhythmia	arrhythmia	NN
cord-261186-4p1cwb2e	16	50	,	,	,
cord-261186-4p1cwb2e	16	51	and	and	CC
cord-261186-4p1cwb2e	16	52	chronic	chronic	JJ
cord-261186-4p1cwb2e	16	53	obstructive	obstructive	JJ
cord-261186-4p1cwb2e	16	54	pulmonary	pulmonary	JJ
cord-261186-4p1cwb2e	16	55	disease	disease	NN
cord-261186-4p1cwb2e	16	56	.	.	.
cord-261186-4p1cwb2e	17	1	The	the	DT
cord-261186-4p1cwb2e	17	2	researchers	researcher	NNS
cord-261186-4p1cwb2e	17	3	argue	argue	VBP
cord-261186-4p1cwb2e	17	4	that	that	IN
cord-261186-4p1cwb2e	17	5	the	the	DT
cord-261186-4p1cwb2e	17	6	presence	presence	NN
cord-261186-4p1cwb2e	17	7	of	of	IN
cord-261186-4p1cwb2e	17	8	underlying	underlie	VBG
cord-261186-4p1cwb2e	17	9	cardiovascular	cardiovascular	JJ
cord-261186-4p1cwb2e	17	10	disease	disease	NN
cord-261186-4p1cwb2e	17	11	could	could	MD
cord-261186-4p1cwb2e	17	12	represent	represent	VB
cord-261186-4p1cwb2e	17	13	a	a	DT
cord-261186-4p1cwb2e	17	14	partial	partial	JJ
cord-261186-4p1cwb2e	17	15	explanation	explanation	NN
cord-261186-4p1cwb2e	17	16	of	of	IN
cord-261186-4p1cwb2e	17	17	the	the	DT
cord-261186-4p1cwb2e	17	18	cardiovascular	cardiovascular	JJ
cord-261186-4p1cwb2e	17	19	toxicity	toxicity	NN
cord-261186-4p1cwb2e	17	20	associated	associate	VBN
cord-261186-4p1cwb2e	17	21	with	with	IN
cord-261186-4p1cwb2e	17	22	the	the	DT
cord-261186-4p1cwb2e	17	23	use	use	NN
cord-261186-4p1cwb2e	17	24	of	of	IN
cord-261186-4p1cwb2e	17	25	CQ	CQ	NNP
cord-261186-4p1cwb2e	17	26	or	or	CC
cord-261186-4p1cwb2e	17	27	HCQ	HCQ	NNP
cord-261186-4p1cwb2e	17	28	particularly	particularly	RB
cord-261186-4p1cwb2e	17	29	with	with	IN
cord-261186-4p1cwb2e	17	30	the	the	DT
cord-261186-4p1cwb2e	17	31	combination	combination	NN
cord-261186-4p1cwb2e	17	32	of	of	IN
cord-261186-4p1cwb2e	17	33	macrolides	macrolide	NNS
cord-261186-4p1cwb2e	17	34	.	.	.
cord-261186-4p1cwb2e	18	1	Notably	notably	RB
cord-261186-4p1cwb2e	18	2	,	,	,
cord-261186-4p1cwb2e	18	3	a	a	DT
cord-261186-4p1cwb2e	18	4	propensity	propensity	NN
cord-261186-4p1cwb2e	18	5	score	score	NN
cord-261186-4p1cwb2e	18	6	matching	matching	NN
cord-261186-4p1cwb2e	18	7	analysis	analysis	NN
cord-261186-4p1cwb2e	18	8	was	be	VBD
cord-261186-4p1cwb2e	18	9	conducted	conduct	VBN
cord-261186-4p1cwb2e	18	10	to	to	TO
cord-261186-4p1cwb2e	18	11	mitigate	mitigate	VB
cord-261186-4p1cwb2e	18	12	potential	potential	JJ
cord-261186-4p1cwb2e	18	13	confounders	confounder	NNS
cord-261186-4p1cwb2e	18	14	.	.	.
cord-261186-4p1cwb2e	19	1	Moreover	moreover	RB
cord-261186-4p1cwb2e	19	2	,	,	,
cord-261186-4p1cwb2e	19	3	Cox	Cox	NNP
cord-261186-4p1cwb2e	19	4	proportional	proportional	JJ
cord-261186-4p1cwb2e	19	5	hazards	hazard	NNS
cord-261186-4p1cwb2e	19	6	models	model	NNS
cord-261186-4p1cwb2e	19	7	and	and	CC
cord-261186-4p1cwb2e	19	8	a	a	DT
cord-261186-4p1cwb2e	19	9	tipping	tipping	NN
cord-261186-4p1cwb2e	19	10	-	-	HYPH
cord-261186-4p1cwb2e	19	11	point	point	NN
cord-261186-4p1cwb2e	19	12	analysis	analysis	NN
cord-261186-4p1cwb2e	19	13	were	be	VBD
cord-261186-4p1cwb2e	19	14	performed	perform	VBN
cord-261186-4p1cwb2e	19	15	to	to	TO
cord-261186-4p1cwb2e	19	16	assess	assess	VB
cord-261186-4p1cwb2e	19	17	the	the	DT
cord-261186-4p1cwb2e	19	18	robustness	robustness	NN
cord-261186-4p1cwb2e	19	19	of	of	IN
cord-261186-4p1cwb2e	19	20	the	the	DT
cord-261186-4p1cwb2e	19	21	estimates	estimate	NNS
cord-261186-4p1cwb2e	19	22	.	.	.
cord-261186-4p1cwb2e	20	1	Clearly	clearly	RB
cord-261186-4p1cwb2e	20	2	,	,	,
cord-261186-4p1cwb2e	20	3	this	this	DT
cord-261186-4p1cwb2e	20	4	study	study	NN
cord-261186-4p1cwb2e	20	5	represents	represent	VBZ
cord-261186-4p1cwb2e	20	6	a	a	DT
cord-261186-4p1cwb2e	20	7	potential	potential	JJ
cord-261186-4p1cwb2e	20	8	landmark	landmark	NN
cord-261186-4p1cwb2e	20	9	regarding	regard	VBG
cord-261186-4p1cwb2e	20	10	safety	safety	NN
cord-261186-4p1cwb2e	20	11	and	and	CC
cord-261186-4p1cwb2e	20	12	efficacy	efficacy	NN
cord-261186-4p1cwb2e	20	13	of	of	IN
cord-261186-4p1cwb2e	20	14	CQ	CQ	NNP
cord-261186-4p1cwb2e	20	15	and	and	CC
cord-261186-4p1cwb2e	20	16	HCQ	HCQ	NNP
cord-261186-4p1cwb2e	20	17	,	,	,
cord-261186-4p1cwb2e	20	18	either	either	CC
cord-261186-4p1cwb2e	20	19	alone	alone	RB
cord-261186-4p1cwb2e	20	20	or	or	CC
cord-261186-4p1cwb2e	20	21	in	in	IN
cord-261186-4p1cwb2e	20	22	combination	combination	NN
cord-261186-4p1cwb2e	20	23	with	with	IN
cord-261186-4p1cwb2e	20	24	macrolides	macrolide	NNS
cord-261186-4p1cwb2e	20	25	,	,	,
cord-261186-4p1cwb2e	20	26	for	for	IN
cord-261186-4p1cwb2e	20	27	the	the	DT
cord-261186-4p1cwb2e	20	28	treatment	treatment	NN
cord-261186-4p1cwb2e	20	29	of	of	IN
cord-261186-4p1cwb2e	20	30	COVID-19	COVID-19	NNP
cord-261186-4p1cwb2e	20	31	.	.	.
cord-261186-4p1cwb2e	21	1	However	however	RB
cord-261186-4p1cwb2e	21	2	,	,	,
cord-261186-4p1cwb2e	21	3	the	the	DT
cord-261186-4p1cwb2e	21	4	observational	observational	JJ
cord-261186-4p1cwb2e	21	5	retrospective	retrospective	JJ
cord-261186-4p1cwb2e	21	6	design	design	NN
cord-261186-4p1cwb2e	21	7	limits	limit	VBZ
cord-261186-4p1cwb2e	21	8	the	the	DT
cord-261186-4p1cwb2e	21	9	study	study	NN
cord-261186-4p1cwb2e	21	10	's	's	POS
cord-261186-4p1cwb2e	21	11	implications	implication	NNS
cord-261186-4p1cwb2e	21	12	.	.	.
cord-261186-4p1cwb2e	22	1	In	in	IN
cord-261186-4p1cwb2e	22	2	addition	addition	NN
cord-261186-4p1cwb2e	22	3	to	to	IN
cord-261186-4p1cwb2e	22	4	the	the	DT
cord-261186-4p1cwb2e	22	5	cardiotoxic	cardiotoxic	JJ
cord-261186-4p1cwb2e	22	6	considerations	consideration	NNS
cord-261186-4p1cwb2e	22	7	mentioned	mention	VBN
cord-261186-4p1cwb2e	22	8	by	by	IN
cord-261186-4p1cwb2e	22	9	Aggarwal	Aggarwal	NNP
cord-261186-4p1cwb2e	22	10	,	,	,
cord-261186-4p1cwb2e	22	11	et	et	NNP
cord-261186-4p1cwb2e	22	12	al	al	NNP
cord-261186-4p1cwb2e	22	13	(	(	-LRB-
cord-261186-4p1cwb2e	22	14	1	1	CD
cord-261186-4p1cwb2e	22	15	)	)	-RRB-
cord-261186-4p1cwb2e	22	16	,	,	,
cord-261186-4p1cwb2e	22	17	relevant	relevant	JJ
cord-261186-4p1cwb2e	22	18	cardiovascular	cardiovascular	JJ
cord-261186-4p1cwb2e	22	19	side	side	NN
cord-261186-4p1cwb2e	22	20	effects	effect	NNS
cord-261186-4p1cwb2e	22	21	and	and	CC
cord-261186-4p1cwb2e	22	22	toxicities	toxicity	NNS
cord-261186-4p1cwb2e	22	23	associated	associate	VBN
cord-261186-4p1cwb2e	22	24	with	with	IN
cord-261186-4p1cwb2e	22	25	the	the	DT
cord-261186-4p1cwb2e	22	26	use	use	NN
cord-261186-4p1cwb2e	22	27	of	of	IN
cord-261186-4p1cwb2e	22	28	repurposing	repurpose	VBG
cord-261186-4p1cwb2e	22	29	drugs	drug	NNS
cord-261186-4p1cwb2e	22	30	for	for	IN
cord-261186-4p1cwb2e	22	31	the	the	DT
cord-261186-4p1cwb2e	22	32	treatment	treatment	NN
cord-261186-4p1cwb2e	22	33	of	of	IN
cord-261186-4p1cwb2e	22	34	COVID-19	COVID-19	NNP
cord-261186-4p1cwb2e	22	35	have	have	VBP
cord-261186-4p1cwb2e	22	36	been	be	VBN
cord-261186-4p1cwb2e	22	37	stated	state	VBN
cord-261186-4p1cwb2e	22	38	by	by	IN
cord-261186-4p1cwb2e	22	39	researchers	researcher	NNS
cord-261186-4p1cwb2e	22	40	of	of	IN
cord-261186-4p1cwb2e	22	41	cardiovascular	cardiovascular	JJ
cord-261186-4p1cwb2e	22	42	disease	disease	NN
cord-261186-4p1cwb2e	22	43	who	who	WP
cord-261186-4p1cwb2e	22	44	stress	stress	VBP
cord-261186-4p1cwb2e	22	45	the	the	DT
cord-261186-4p1cwb2e	22	46	risk	risk	NN
cord-261186-4p1cwb2e	22	47	of	of	IN
cord-261186-4p1cwb2e	22	48	QT	qt	NN
cord-261186-4p1cwb2e	22	49	interval	interval	NN
cord-261186-4p1cwb2e	22	50	prolongation	prolongation	NN
cord-261186-4p1cwb2e	22	51	,	,	,
cord-261186-4p1cwb2e	22	52	thrombocytopenia	thrombocytopenia	NN
cord-261186-4p1cwb2e	22	53	and	and	CC
cord-261186-4p1cwb2e	22	54	anaemia	anaemia	NN
cord-261186-4p1cwb2e	22	55	specifically	specifically	RB
cord-261186-4p1cwb2e	22	56	with	with	IN
cord-261186-4p1cwb2e	22	57	the	the	DT
cord-261186-4p1cwb2e	22	58	use	use	NN
cord-261186-4p1cwb2e	22	59	of	of	IN
cord-261186-4p1cwb2e	22	60	CQ	CQ	NNP
cord-261186-4p1cwb2e	22	61	and	and	CC
cord-261186-4p1cwb2e	22	62	HCQ	HCQ	NNP
cord-261186-4p1cwb2e	22	63	(	(	-LRB-
cord-261186-4p1cwb2e	22	64	10	10	CD
cord-261186-4p1cwb2e	22	65	)	)	-RRB-
cord-261186-4p1cwb2e	22	66	.	.	.
cord-261186-4p1cwb2e	23	1	In	in	IN
cord-261186-4p1cwb2e	23	2	conclusion	conclusion	NN
cord-261186-4p1cwb2e	23	3	,	,	,
cord-261186-4p1cwb2e	23	4	it	-PRON-	PRP
cord-261186-4p1cwb2e	23	5	is	be	VBZ
cord-261186-4p1cwb2e	23	6	not	not	RB
cord-261186-4p1cwb2e	23	7	clear	clear	JJ
cord-261186-4p1cwb2e	23	8	whether	whether	IN
cord-261186-4p1cwb2e	23	9	the	the	DT
cord-261186-4p1cwb2e	23	10	risk	risk	NN
cord-261186-4p1cwb2e	23	11	of	of	IN
cord-261186-4p1cwb2e	23	12	toxic	toxic	JJ
cord-261186-4p1cwb2e	23	13	effects	effect	NNS
cord-261186-4p1cwb2e	23	14	may	may	MD
cord-261186-4p1cwb2e	23	15	outweigh	outweigh	VB
cord-261186-4p1cwb2e	23	16	the	the	DT
cord-261186-4p1cwb2e	23	17	benefits	benefit	NNS
cord-261186-4p1cwb2e	23	18	of	of	IN
cord-261186-4p1cwb2e	23	19	potential	potential	JJ
cord-261186-4p1cwb2e	23	20	COVID-19	covid-19	CD
cord-261186-4p1cwb2e	23	21	treatments	treatment	NNS
cord-261186-4p1cwb2e	23	22	.	.	.
cord-261186-4p1cwb2e	24	1	A	a	DT
cord-261186-4p1cwb2e	24	2	decisive	decisive	JJ
cord-261186-4p1cwb2e	24	3	answer	answer	NN
cord-261186-4p1cwb2e	24	4	still	still	RB
cord-261186-4p1cwb2e	24	5	awaits	await	VBZ
cord-261186-4p1cwb2e	24	6	the	the	DT
cord-261186-4p1cwb2e	24	7	results	result	NNS
cord-261186-4p1cwb2e	24	8	of	of	IN
cord-261186-4p1cwb2e	24	9	high	high	JJ
cord-261186-4p1cwb2e	24	10	quality	quality	NN
cord-261186-4p1cwb2e	24	11	large	large	JJ
cord-261186-4p1cwb2e	24	12	randomized	randomize	VBN
cord-261186-4p1cwb2e	24	13	controlled	control	VBN
cord-261186-4p1cwb2e	24	14	trials	trial	NNS
cord-261186-4p1cwb2e	24	15	.	.	.
cord-261186-4p1cwb2e	25	1	Cardiovascular	cardiovascular	JJ
cord-261186-4p1cwb2e	25	2	Safety	Safety	NNP
cord-261186-4p1cwb2e	25	3	of	of	IN
cord-261186-4p1cwb2e	25	4	Potential	potential	JJ
cord-261186-4p1cwb2e	25	5	Drugs	drug	NNS
cord-261186-4p1cwb2e	25	6	for	for	IN
cord-261186-4p1cwb2e	25	7	the	the	DT
cord-261186-4p1cwb2e	25	8	Treatment	Treatment	NNP
cord-261186-4p1cwb2e	25	9	of	of	IN
cord-261186-4p1cwb2e	25	10	Coronavirus	Coronavirus	NNP
cord-261186-4p1cwb2e	25	11	Disease	Disease	NNP
cord-261186-4p1cwb2e	25	12	Effect	Effect	NNP
cord-261186-4p1cwb2e	25	13	of	of	IN
cord-261186-4p1cwb2e	25	14	High	High	NNP
cord-261186-4p1cwb2e	25	15	vs	vs	IN
cord-261186-4p1cwb2e	25	16	Low	Low	NNP
cord-261186-4p1cwb2e	25	17	Doses	Doses	NNPS
cord-261186-4p1cwb2e	25	18	of	of	IN
cord-261186-4p1cwb2e	25	19	Chloroquine	Chloroquine	NNP
cord-261186-4p1cwb2e	25	20	Diphosphate	Diphosphate	NNP
cord-261186-4p1cwb2e	25	21	as	as	IN
cord-261186-4p1cwb2e	25	22	Adjunctive	Adjunctive	NNP
cord-261186-4p1cwb2e	25	23	Therapy	Therapy	NNP
cord-261186-4p1cwb2e	25	24	for	for	IN
cord-261186-4p1cwb2e	25	25	Patients	patient	NNS
cord-261186-4p1cwb2e	25	26	Hospitalized	hospitalize	VBN
cord-261186-4p1cwb2e	25	27	With	with	IN
cord-261186-4p1cwb2e	25	28	Severe	severe	JJ
cord-261186-4p1cwb2e	25	29	Acute	acute	JJ
cord-261186-4p1cwb2e	25	30	Respiratory	Respiratory	NNP
cord-261186-4p1cwb2e	25	31	Syndrome	Syndrome	NNP
cord-261186-4p1cwb2e	25	32	Coronavirus	Coronavirus	NNP
cord-261186-4p1cwb2e	25	33	2	2	CD
cord-261186-4p1cwb2e	26	1	(	(	-LRB-
cord-261186-4p1cwb2e	26	2	SARS	SARS	NNP
cord-261186-4p1cwb2e	26	3	-	-	HYPH
cord-261186-4p1cwb2e	26	4	CoV-2	CoV-2	NNP
cord-261186-4p1cwb2e	26	5	)	)	-RRB-
cord-261186-4p1cwb2e	26	6	Infection	infection	NN
cord-261186-4p1cwb2e	26	7	:	:	:
cord-261186-4p1cwb2e	26	8	A	a	DT
cord-261186-4p1cwb2e	26	9	Randomized	Randomized	NNP
cord-261186-4p1cwb2e	26	10	Clinical	Clinical	NNP
cord-261186-4p1cwb2e	26	11	Trial	Trial	NNP
cord-261186-4p1cwb2e	26	12	Clinical	clinical	JJ
cord-261186-4p1cwb2e	26	13	and	and	CC
cord-261186-4p1cwb2e	26	14	microbiological	microbiological	JJ
cord-261186-4p1cwb2e	26	15	effect	effect	NN
cord-261186-4p1cwb2e	26	16	of	of	IN
cord-261186-4p1cwb2e	26	17	a	a	DT
cord-261186-4p1cwb2e	26	18	combination	combination	NN
cord-261186-4p1cwb2e	26	19	of	of	IN
cord-261186-4p1cwb2e	26	20	hydroxychloroquine	hydroxychloroquine	NN
cord-261186-4p1cwb2e	26	21	and	and	CC
cord-261186-4p1cwb2e	26	22	azithromycin	azithromycin	NNP
cord-261186-4p1cwb2e	26	23	in	in	IN
cord-261186-4p1cwb2e	26	24	80	80	CD
cord-261186-4p1cwb2e	26	25	COVID-19	covid-19	JJ
cord-261186-4p1cwb2e	26	26	patients	patient	NNS
cord-261186-4p1cwb2e	26	27	with	with	IN
cord-261186-4p1cwb2e	26	28	at	at	RB
cord-261186-4p1cwb2e	26	29	least	least	JJS
cord-261186-4p1cwb2e	26	30	a	a	DT
cord-261186-4p1cwb2e	26	31	six	six	CD
cord-261186-4p1cwb2e	26	32	-	-	HYPH
cord-261186-4p1cwb2e	26	33	day	day	NN
cord-261186-4p1cwb2e	26	34	follow	follow	VB
cord-261186-4p1cwb2e	26	35	up	up	RP
cord-261186-4p1cwb2e	26	36	:	:	:
cord-261186-4p1cwb2e	26	37	A	a	DT
cord-261186-4p1cwb2e	26	38	pilot	pilot	NN
cord-261186-4p1cwb2e	26	39	observational	observational	JJ
cord-261186-4p1cwb2e	26	40	study	study	NN
cord-261186-4p1cwb2e	27	1	The	the	DT
cord-261186-4p1cwb2e	27	2	QT	QT	NNP
cord-261186-4p1cwb2e	27	3	interval	interval	NN
cord-261186-4p1cwb2e	27	4	in	in	IN
cord-261186-4p1cwb2e	27	5	patients	patient	NNS
cord-261186-4p1cwb2e	27	6	with	with	IN
cord-261186-4p1cwb2e	27	7	COVID-19	COVID-19	NNP
cord-261186-4p1cwb2e	27	8	treated	treat	VBN
cord-261186-4p1cwb2e	27	9	with	with	IN
cord-261186-4p1cwb2e	27	10	hydroxychloroquine	hydroxychloroquine	NN
cord-261186-4p1cwb2e	27	11	and	and	CC
cord-261186-4p1cwb2e	27	12	azithromycin	azithromycin	NNP
cord-261186-4p1cwb2e	27	13	Assessment	Assessment	NNP
cord-261186-4p1cwb2e	27	14	of	of	IN
cord-261186-4p1cwb2e	27	15	QT	QT	NNP
cord-261186-4p1cwb2e	27	16	Intervals	Intervals	NNPS
cord-261186-4p1cwb2e	27	17	in	in	IN
cord-261186-4p1cwb2e	27	18	a	a	DT
cord-261186-4p1cwb2e	27	19	case	case	NN
cord-261186-4p1cwb2e	27	20	series	series	NN
cord-261186-4p1cwb2e	27	21	of	of	IN
cord-261186-4p1cwb2e	27	22	patients	patient	NNS
cord-261186-4p1cwb2e	27	23	with	with	IN
cord-261186-4p1cwb2e	27	24	coronavirus	coronavirus	NN
cord-261186-4p1cwb2e	27	25	disease	disease	NN
cord-261186-4p1cwb2e	27	26	2019	2019	CD
cord-261186-4p1cwb2e	27	27	(	(	-LRB-
cord-261186-4p1cwb2e	27	28	COVID-19	COVID-19	NNP
cord-261186-4p1cwb2e	27	29	)	)	-RRB-
cord-261186-4p1cwb2e	27	30	infection	infection	NN
cord-261186-4p1cwb2e	27	31	treated	treat	VBN
cord-261186-4p1cwb2e	27	32	with	with	IN
cord-261186-4p1cwb2e	27	33	hydroxychloroquine	hydroxychloroquine	NN
cord-261186-4p1cwb2e	27	34	alone	alone	JJ
cord-261186-4p1cwb2e	27	35	or	or	CC
cord-261186-4p1cwb2e	27	36	in	in	IN
cord-261186-4p1cwb2e	27	37	combination	combination	NN
cord-261186-4p1cwb2e	27	38	with	with	IN
cord-261186-4p1cwb2e	27	39	azithromycin	azithromycin	NNP
cord-261186-4p1cwb2e	27	40	in	in	IN
cord-261186-4p1cwb2e	27	41	an	an	DT
cord-261186-4p1cwb2e	27	42	intensive	intensive	JJ
cord-261186-4p1cwb2e	27	43	care	care	NN
cord-261186-4p1cwb2e	27	44	unit	unit	NN
cord-261186-4p1cwb2e	27	45	Risk	Risk	NNP
cord-261186-4p1cwb2e	27	46	of	of	IN
cord-261186-4p1cwb2e	27	47	QT	QT	NNP
cord-261186-4p1cwb2e	27	48	interval	interval	NN
cord-261186-4p1cwb2e	27	49	prolongation	prolongation	NN
cord-261186-4p1cwb2e	27	50	associated	associate	VBN
cord-261186-4p1cwb2e	27	51	with	with	IN
cord-261186-4p1cwb2e	27	52	use	use	NN
cord-261186-4p1cwb2e	27	53	of	of	IN
cord-261186-4p1cwb2e	27	54	hydroxychloroquine	hydroxychloroquine	NN
cord-261186-4p1cwb2e	27	55	with	with	IN
cord-261186-4p1cwb2e	27	56	or	or	CC
cord-261186-4p1cwb2e	27	57	without	without	IN
cord-261186-4p1cwb2e	27	58	concomitant	concomitant	JJ
cord-261186-4p1cwb2e	27	59	azithromycin	azithromycin	NNS
cord-261186-4p1cwb2e	27	60	among	among	IN
cord-261186-4p1cwb2e	27	61	hospitalized	hospitalize	VBN
cord-261186-4p1cwb2e	27	62	patients	patient	NNS
cord-261186-4p1cwb2e	27	63	testing	test	VBG
cord-261186-4p1cwb2e	27	64	positive	positive	JJ
cord-261186-4p1cwb2e	27	65	for	for	IN
cord-261186-4p1cwb2e	27	66	coronavirus	coronavirus	NN
cord-261186-4p1cwb2e	27	67	2019	2019	CD
cord-261186-4p1cwb2e	27	68	(	(	-LRB-
cord-261186-4p1cwb2e	27	69	COVID-19	COVID-19	NNP
cord-261186-4p1cwb2e	27	70	)	)	-RRB-
cord-261186-4p1cwb2e	27	71	infection	infection	NN
cord-261186-4p1cwb2e	27	72	.	.	.
cord-261186-4p1cwb2e	28	1	JAMA	JAMA	NNP
cord-261186-4p1cwb2e	29	1	Cardiol	Cardiol	NNP
cord-261186-4p1cwb2e	29	2	Clinical	clinical	JJ
cord-261186-4p1cwb2e	29	3	efficacy	efficacy	NN
cord-261186-4p1cwb2e	29	4	of	of	IN
cord-261186-4p1cwb2e	29	5	hydroxychloroquine	hydroxychloroquine	NN
cord-261186-4p1cwb2e	29	6	in	in	IN
cord-261186-4p1cwb2e	29	7	patients	patient	NNS
cord-261186-4p1cwb2e	29	8	with	with	IN
cord-261186-4p1cwb2e	29	9	covid-19	covid-19	NNP
cord-261186-4p1cwb2e	29	10	pneumonia	pneumonia	NN
cord-261186-4p1cwb2e	29	11	who	who	WP
cord-261186-4p1cwb2e	29	12	require	require	VBP
cord-261186-4p1cwb2e	29	13	oxygen	oxygen	NN
cord-261186-4p1cwb2e	29	14	:	:	:
cord-261186-4p1cwb2e	29	15	observational	observational	JJ
cord-261186-4p1cwb2e	29	16	comparative	comparative	JJ
cord-261186-4p1cwb2e	29	17	study	study	NN
cord-261186-4p1cwb2e	29	18	using	use	VBG
cord-261186-4p1cwb2e	29	19	routine	routine	JJ
cord-261186-4p1cwb2e	29	20	care	care	NN
cord-261186-4p1cwb2e	29	21	data	data	NNPS
cord-261186-4p1cwb2e	29	22	Association	Association	NNP
cord-261186-4p1cwb2e	29	23	of	of	IN
cord-261186-4p1cwb2e	29	24	Treatment	Treatment	NNP
cord-261186-4p1cwb2e	29	25	With	with	IN
cord-261186-4p1cwb2e	29	26	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-261186-4p1cwb2e	29	27	or	or	CC
cord-261186-4p1cwb2e	29	28	Azithromycin	Azithromycin	NNP
cord-261186-4p1cwb2e	29	29	With	with	IN
cord-261186-4p1cwb2e	29	30	In	in	IN
cord-261186-4p1cwb2e	29	31	-	-	HYPH
cord-261186-4p1cwb2e	29	32	Hospital	hospital	NN
cord-261186-4p1cwb2e	29	33	Mortality	mortality	NN
cord-261186-4p1cwb2e	29	34	in	in	IN
cord-261186-4p1cwb2e	29	35	Patients	patient	NNS
cord-261186-4p1cwb2e	29	36	With	with	IN
cord-261186-4p1cwb2e	29	37	COVID-19	COVID-19	NNP
cord-261186-4p1cwb2e	29	38	in	in	IN
cord-261186-4p1cwb2e	29	39	New	New	NNP
cord-261186-4p1cwb2e	29	40	York	York	NNP
cord-261186-4p1cwb2e	29	41	State	State	NNP
cord-261186-4p1cwb2e	29	42	Hydroxychloroquine	Hydroxychloroquine	NNP
cord-261186-4p1cwb2e	29	43	or	or	CC
cord-261186-4p1cwb2e	29	44	chloroquine	chloroquine	NN
cord-261186-4p1cwb2e	29	45	with	with	IN
cord-261186-4p1cwb2e	29	46	or	or	CC
cord-261186-4p1cwb2e	29	47	without	without	IN
cord-261186-4p1cwb2e	29	48	a	a	DT
cord-261186-4p1cwb2e	29	49	macrolide	macrolide	NN
cord-261186-4p1cwb2e	29	50	for	for	IN
cord-261186-4p1cwb2e	29	51	treatment	treatment	NN
cord-261186-4p1cwb2e	29	52	of	of	IN
cord-261186-4p1cwb2e	29	53	COVID-19	COVID-19	NNP
cord-261186-4p1cwb2e	29	54	:	:	:
cord-261186-4p1cwb2e	29	55	a	a	DT
cord-261186-4p1cwb2e	29	56	multinational	multinational	JJ
cord-261186-4p1cwb2e	29	57	registry	registry	NN
cord-261186-4p1cwb2e	29	58	analysis	analysis	NN
cord-261186-4p1cwb2e	29	59	.	.	.
cord-261186-4p1cwb2e	30	1	The	the	DT
cord-261186-4p1cwb2e	30	2	Lancet	Lancet	NNP
cord-261186-4p1cwb2e	30	3	COVID-19	COVID-19	NNP
cord-261186-4p1cwb2e	30	4	and	and	CC
cord-261186-4p1cwb2e	30	5	the	the	DT
cord-261186-4p1cwb2e	30	6	cardiovascular	cardiovascular	JJ
cord-261186-4p1cwb2e	30	7	system	system	NN
cord-261186-4p1cwb2e	30	8	:	:	:
cord-261186-4p1cwb2e	30	9	implications	implication	NNS
cord-261186-4p1cwb2e	30	10	for	for	IN
cord-261186-4p1cwb2e	30	11	risk	risk	NN
cord-261186-4p1cwb2e	30	12	assessment	assessment	NN
cord-261186-4p1cwb2e	30	13	,	,	,
cord-261186-4p1cwb2e	30	14	diagnosis	diagnosis	NN
cord-261186-4p1cwb2e	30	15	,	,	,
cord-261186-4p1cwb2e	30	16	and	and	CC
cord-261186-4p1cwb2e	30	17	treatment	treatment	NN
cord-261186-4p1cwb2e	30	18	options	option	NNS